Homebiotech

biotech

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

SPT supports UKHSA genomics surveillance project to strengthen global health security

Jim Cornall - February 23, 2024

biotech

New nanosensors make diagnostic procedures more sensitive

Jim Cornall - February 15, 2024

biotech

Watch: PhaseV at Bio-Europe

Jim Cornall - January 11, 2024

biotech

DeepMirror launches molecular drug design software

Jim Cornall - December 12, 2023

biotech

Video: Lithuanian company Caszyme at forefront of gene editing

Jim Cornall - November 14, 2023

biotech

Kuano raises £1.8M to accelerate quantum drug discovery

Jim Cornall - September 14, 2023

biotech

Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning

Jim Cornall - August 31, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

1...949596 Page 95 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026 0

On a genetic level, RNA viruses share common structural elements. The RNA of their genomes has strings, folds, and knot-like features that interact with...

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0